Breaking News

Goldman to Buy Back $3.15 Billion of Mortgage Securities Under Settlement With FHFA
Tweet TWEET

Edwards Lifesciences Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Announce Investigation of

  Edwards Lifesciences Shareholder Alert: Former SEC Attorney Willie Briscoe
  and Powers Taylor LLP Announce Investigation of Possible Breaches of
  Fiduciary Duty

Business Wire

DALLAS -- September 24, 2013

Former United States Securities and Exchange Commission attorney Willie
Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation
firm of Powers Taylor LLP announce that the firms are investigating legal
claims against the officers and Board of Directors of Edwards Lifesciences
Corporation (“Edwards Lifesciences” or “Company”) (NYSE:EW) related to
potential securities violations between April 25, 2012 and April 23, 2013 (the
“Class Period”).

If you are an affected investor and you want to learn more about the lawsuit
or join the action, contact Willie Briscoe at The Briscoe Law Firm, PLLC,
(214) 239-4568, or via email at WBriscoe@TheBriscoeLawFirm.com, or Zachary
Groover at Powers Taylor, LLP, toll free (877) 728-9607, via e-mail at
zach@powerstyalor.com. There is no cost or fee to you.

In a recently filed federal class action complaint, Edwards Lifesciences and
certain of its officers and directors were charged with violating certain
provisions of the Securities Exchange Act of 1934. Specifically, the complaint
alleges that defendants’ misrepresented, among other things, that (a) the
adoption of SAPIEN was weaker than the Company proclaimed due to concerns
among physicians over the risks and complexity of the procedure to implant the
valve; (b) the Company’s outlook for sales and earnings per share was
significantly weaker than the optimistic guidance Defendants offered to
investors; and (c) as a result of the above, the positive statements released
by Defendants regarding the Company’s operations, forecasts and outlook were
unfounded. According to the complaint, when the truth came out, the share
price of Edwards Lifesciences dropped dramatically.

“Recent revelations about alleged improper business practices and procedures
regarding key aspects of Edwards Lifesciences’ business and other misleading
financial statements have prompted the firms to investigate possible breaches
of fiduciary duties and other violations of state law by Edwards Lifesciences’
officers and directors. Based on our investigation, we are prepared to pursue
litigation to preserve the company and the value of Edwards Lifesciences stock
for all shareholders,” said shareholder rights attorney Willie Briscoe.

The Briscoe Law Firm, PLLC is a full service business litigation, commercial
transaction, and public advocacy firm with more than 20 years of experience in
complex litigation and transactional matters.

Powers Taylor, LLP is a boutique litigation law firm that handles a variety of
complex business litigation matters, including claims of investor and
stockholder fraud, shareholder oppression, shareholder derivative suits, and
security class actions.

Contact:

The Briscoe Law Firm, PLLC
Willie Briscoe, 214-239-4568,
WBriscoe@TheBriscoeLawFirm.com
or
Powers Taylor, LLP
Zachary Groover, 877-728-9607
zach@powerstyalor.com
 
Press spacebar to pause and continue. Press esc to stop.